title: Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward; authors' reply.
authors.affiliation: Department of Gastroenterology and Hepatology, Fundación Santa Fe de Bogotá y Universidad de los Andes, Facultad de Medicina, Bogotá, Colombia. fersi17@yahoo.com
authors.forename: F
authors.initials: F
authors.lastname: Sierra
authors.forename: J D
authors.initials: JD
authors.lastname: Forero
authors.forename: M
authors.initials: M
authors.lastname: Rey
authors.forename: M L
authors.initials: ML
authors.lastname: Botero
authors.forename: A
authors.initials: A
authors.lastname: Cárdenas
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D010437:Peptic Ulcer / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors